These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 34995400)

  • 1. Use of Modeling and Simulation to Predict the Influence of Triazole Antifungal Agents on the Pharmacokinetics of Crizotinib.
    Chen L; Li L; Chen W
    Clin Pharmacol Drug Dev; 2022 Jun; 11(6):724-733. PubMed ID: 34995400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting the Effects of Different Triazole Antifungal Agents on the Pharmacokinetics of Tamoxifen.
    Chen L; Zhu L; Li M; Li N; Qi F; Wang N
    AAPS PharmSciTech; 2019 Jan; 20(1):24. PubMed ID: 30604153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of modeling and simulation to predict the influence of triazole antifungal agents on the pharmacokinetics of zanubrutinib and acalabrutinib.
    Chen L; Li C; Bai H; Li L; Chen W
    Front Pharmacol; 2022; 13():960186. PubMed ID: 36299883
    [No Abstract]   [Full Text] [Related]  

  • 4. The Influence of Different Triazole Antifungal Agents on the Pharmacokinetics of Cyclophosphamide.
    Cai T; Liao Y; Chen Z; Zhu Y; Qiu X
    Ann Pharmacother; 2020 Jul; 54(7):676-683. PubMed ID: 31893943
    [No Abstract]   [Full Text] [Related]  

  • 5. Cross-reactivity between voriconazole, fluconazole and itraconazole.
    Benjamin Lash D; Jolliff J; Munoz A; Heidari A
    J Clin Pharm Ther; 2016 Oct; 41(5):566-7. PubMed ID: 27430151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triazole antifungal agents in invasive fungal infections: a comparative review.
    Lass-Flörl C
    Drugs; 2011 Dec; 71(18):2405-19. PubMed ID: 22141384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of voriconazole administered concomitantly with fluconazole and population-based simulation for sequential use.
    Damle B; Varma MV; Wood N
    Antimicrob Agents Chemother; 2011 Nov; 55(11):5172-7. PubMed ID: 21876043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Analysis of Adverse Drug Reactions between Vincristine and Triazoles in Children with Acute Lymphoblastic Leukemia.
    Yang L; Yu L; Chen X; Hu Y; Wang B
    Med Sci Monit; 2015 Jun; 21():1656-61. PubMed ID: 26050202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Why do lung transplant patients discontinue triazole prophylaxis?
    Pennington KM; Razonable RR; Peters S; Scott JP; Wylam M; Daly RC; Kennedy CC
    Transpl Infect Dis; 2019 Jun; 21(3):e13067. PubMed ID: 30866168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the inhibitory effect of ketoconazole, voriconazole, fluconazole, and itraconazole on the pharmacokinetics of bosentan and its corresponding active metabolite hydroxy bosentan in rats.
    Chen M; Zhang X; Chen Y; Sun W; Wang Z; Huang C; Hu G; Chen R
    Xenobiotica; 2020 Mar; 50(3):280-287. PubMed ID: 31199171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antifungal susceptibility profiles of Candida species to triazole: application of new CLSI species-specific clinical breakpoints and epidemiological cutoff values for characterization of antifungal resistance].
    Karabıçak N; Alem N
    Mikrobiyol Bul; 2016 Jan; 50(1):122-32. PubMed ID: 27058336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluconazole exposure rather than clonal spreading is correlated with the emergence of Candida glabrata with cross-resistance to triazole antifungal agents.
    Chen TC; Chen YH; Chen YC; Lu PL
    Kaohsiung J Med Sci; 2012 Jun; 28(6):306-15. PubMed ID: 22632885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and pharmacodynamics of antifungals in children and their clinical implications.
    Stockmann C; Constance JE; Roberts JK; Olson J; Doby EH; Ampofo K; Stiers J; Spigarelli MG; Sherwin CM
    Clin Pharmacokinet; 2014 May; 53(5):429-54. PubMed ID: 24595533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and pharmacokinetics of coadministered voriconazole and anidulafungin.
    Dowell JA; Schranz J; Baruch A; Foster G
    J Clin Pharmacol; 2005 Dec; 45(12):1373-82. PubMed ID: 16291712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifungal prophylaxis with posaconazole vs. fluconazole or itraconazole in pediatric patients with neutropenia.
    Döring M; Eikemeier M; Cabanillas Stanchi KM; Hartmann U; Ebinger M; Schwarze CP; Schulz A; Handgretinger R; Müller I
    Eur J Clin Microbiol Infect Dis; 2015 Jun; 34(6):1189-200. PubMed ID: 25680318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Voriconazole susceptibility of yeasts isolated from the mouths of patients with advanced cancer.
    Bagg J; Sweeney MP; Davies AN; Jackson MS; Brailsford S
    J Med Microbiol; 2005 Oct; 54(Pt 10):959-964. PubMed ID: 16157550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Drug-drug interaction of antifungal drugs].
    Niwa T; Shiraga T; Takagi A
    Yakugaku Zasshi; 2005 Oct; 125(10):795-805. PubMed ID: 16205037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Voriconazole: a new triazole antifungal.
    Sabo JA; Abdel-Rahman SM
    Ann Pharmacother; 2000 Sep; 34(9):1032-43. PubMed ID: 10981251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Head-to-head comparison of inhibitory and fungicidal activities of fluconazole, itraconazole, voriconazole, posaconazole, and isavuconazole against clinical isolates of Trichosporon asahii.
    Hazirolan G; Canton E; Sahin S; Arikan-Akdagli S
    Antimicrob Agents Chemother; 2013 Oct; 57(10):4841-7. PubMed ID: 23877683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro investigation of antifungal activities of phenotypic variation Candida albicans strains against fluconazole, itraconazole and voriconazole.
    Cetinkaya Z; Kiraz N
    Nihon Ishinkin Gakkai Zasshi; 2005; 46(3):197-201. PubMed ID: 16094296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.